U.S. flag

An official website of the United States government

GRCh37/hg19 15q21.3(chr15:55772371-57880518)x1 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 1, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001827704.1

Allele description [Variation Report for GRCh37/hg19 15q21.3(chr15:55772371-57880518)x1]

GRCh37/hg19 15q21.3(chr15:55772371-57880518)x1

Genes:
Variant type:
copy number loss
Cytogenetic location:
15q21.3
Genomic location:
Chr15: 55772371 - 57880518 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 15q21.3(chr15:55772371-57880518)x1
HGVS:
NC_000015.9:g.(?_55772371)_(57880518_?)del

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002096143Quest Diagnostics Nichols Institute San Juan Capistrano
no assertion criteria provided
Pathogenic
(Apr 1, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV002096143.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The copy number loss of 15q21.3 involves several protein-coding genes and is expected to cause phenotypic and/or developmental abnormalities. It includes TCF12 (OMIM 600480) and multiple exons (NM_130810.4) of the 5' portion of DNAAF4 (OMIM 608706). Haploinsufficiency of TCF12 is associated with autosomal dominant craniosynostosis-3 (OMIM 615314), which is characterized by premature fusion of the cranial sutures leading to skull deformity and, in some cases, increased intracranial pressure. If left untreated, the increase in intracranial pressure can result in permanent neurodevelopmental disability. Affected individuals may also have mild dysmorphic facial features and limb anomalies. TCF12 pathogenic variants are frequently inherited from an unaffected parent and familial segregations with reduced penetrance have been reported (Sharma et al., Nat Genet 2013;45(3):304-7, PMID: 23354436). Additionally, heterozygous sequence variants of DNAAF4 are associated with autosomal dominant susceptibility to dyslexia-1 (OMIM 127700). There are two genes in this copy number loss that are associated with autosomal recessive disorders: DNAAF4 and MNS1 (OMIM 610766).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 11, 2022